KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medpace Holdings (MEDP) Return on Equity (2016 - 2025)

Historic Return on Equity for Medpace Holdings (MEDP) over the last 10 years, with Q3 2025 value amounting to 1.86%.

  • Medpace Holdings' Return on Equity rose 14100.0% to 1.86% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.86%, marking a year-over-year increase of 14100.0%. This contributed to the annual value of 0.58% for FY2024, which is 100.0% down from last year.
  • Medpace Holdings' Return on Equity amounted to 1.86% in Q3 2025, which was up 14100.0% from 1.09% recorded in Q2 2025.
  • In the past 5 years, Medpace Holdings' Return on Equity ranged from a high of 1.86% in Q3 2025 and a low of 0.19% during Q1 2021
  • Over the past 5 years, Medpace Holdings' median Return on Equity value was 0.51% (recorded in 2024), while the average stood at 0.58%.
  • As far as peak fluctuations go, Medpace Holdings' Return on Equity crashed by -2500bps in 2024, and later surged by 14100bps in 2025.
  • Medpace Holdings' Return on Equity (Quarter) stood at 0.2% in 2021, then soared by 239bps to 0.67% in 2022, then decreased by -18bps to 0.55% in 2023, then fell by -14bps to 0.47% in 2024, then skyrocketed by 292bps to 1.86% in 2025.
  • Its Return on Equity stands at 1.86% for Q3 2025, versus 1.09% for Q2 2025 and 0.59% for Q1 2025.